Outsourcing capacity AnazaoHealth operates a 503B FDA-Registered Outsourcing Facility in Las Vegas, NV, in addition to a traditional 503A patient-specific pharmacy. This positions the company to support large-volume compounding for clinics, hospitals, and health systems seeking scalable, compliant production and white-label pharmaceutical solutions.

Specialty focus With expertise in nuclear medicine, pain management, and intrathecal customized medications, AnazaoHealth can target specialty clinics, oncology centers, pain management groups, nuclear medicine facilities, and wellness pharmacies seeking specialized compounded preparations.

Strategic partnerships Historical ties with Fagron and ongoing reputation in nuclear and compounding verticals suggest opportunities for channel partnerships, distributor collaborations, and co-marketing with other players in the specialty pharma and outsourcing ecosystem.

Regional presence Headquartered in Tampa with the Outsourcing Facility in Las Vegas, there is potential to pursue new regional contracts in both the Southeast and West Coast, particularly with healthcare systems and ambulatory sites seeking compliant 503B supply plus service capabilities.

Growth signals Revenue in the estimated range of $100M-$250M and a mid-size employee base indicate capacity for expanding to additional product lines, payer contracts, and expanded patient-specific services aimed at high-value therapeutic areas in the specialty pharmacy space.